Atheroprotective effects of HDL: beyond reverse cholesterol transport.
about
HDL apolipoprotein-related peptides in the treatment of atherosclerosis and other inflammatory disordersHDL proteome in hemodialysis patients: a quantitative nanoflow liquid chromatography-tandem mass spectrometry approachThe helix bundle: a reversible lipid binding motifDysfunctional HDL as a diagnostic and therapeutic targetA2A adenosine receptor stimulation decreases foam cell formation by enhancing ABCA1-dependent cholesterol efflux.Insights into atherosclerosis using nanotechnologyHDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells.Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients.ATP Synthase β-Chain Overexpression in SR-BI Knockout Mice Increases HDL Uptake and Reduces Plasma HDL LevelHigh-density lipoprotein suppresses the type I interferon response, a family of potent antiviral immunoregulators, in macrophages challenged with lipopolysaccharide.Hepatic trans-Golgi action coordinated by the GTPase ARFRP1 is crucial for lipoprotein lipidation and assembly.Enzymatic assessment of cholesterol on electrophoresis gels for estimating HDL size distribution and plasma concentrations of HDL subclasses.Salutary effects of hemodialysis on low-density lipoprotein proinflammatory and high-density lipoprotein anti-inflammatory properties in patient with end-stage renal disease.In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide.Macrophages, dendritic cells, and regression of atherosclerosis.Cholesterol Metabolism in CKDThe biological properties of iron oxide core high-density lipoprotein in experimental atherosclerosis.Neutrophil effector responses are suppressed by secretory phospholipase A2 modified HDL.Adenoviral expression of human lecithin-cholesterol acyltransferase in nonhuman primates leads to an antiatherogenic lipoprotein phenotype by increasing high-density lipoprotein and lowering low-density lipoproteinEnergy restriction and exercise modulate angiopoietins and vascular endothelial growth factor expression in the cavernous tissue of high-fat diet-fed ratsAnnexin A6 is highly abundant in monocytes of obese and type 2 diabetic individuals and is downregulated by adiponectin in vitroSerum 2-methoxyestradiol, an estrogen metabolite, is positively associated with serum HDL-C in a population-based sample.High-density lipoprotein-based contrast agents for multimodal imaging of atherosclerosis.Apolipoprotein A-I and A-I mimetic peptides: a role in atherosclerosisAssessing the functional properties of high-density lipoproteins: an emerging concept in cardiovascular research.High-density lipoprotein and atherosclerosis regression: evidence from preclinical and clinical studiesThe role of HDL in plaque stabilization and regression: basic mechanisms and clinical implications.An integrated approach for the mechanisms responsible for atherosclerotic plaque regressionAMPK activation enhances the anti-atherogenic effects of high density lipoproteins in apoE-/- mice.Increased atherothrombotic markers and endothelial dysfunction in steroid users.Atheroregressive Potential of the Treatment with a Chimeric Monoclonal Antibody against Sulfated Glycosaminoglycans on Pre-existing Lesions in Apolipoprotein E-Deficient Mice.Apolipoprotein C-III in the high-density lipoprotein proteome of cerebral lacunar infarction patients impairs its anti-inflammatory function.Oxidative stress status in congenital hypogonadism: an appraisal.Petroleum ether extract of Njavara rice (Oryza sativa) bran upregulates the JAK2-STAT3-mediated anti-inflammatory profile in macrophages and aortic endothelial cells promoting regression of atherosclerosis.
P2860
Q27691344-0CF5420B-85EB-4204-9BC8-777583758902Q28481613-A2A9EFD4-5381-4476-B2CA-F7DF7402EA69Q33598704-4D8CB7D8-DD9C-4AB2-81C5-2D712A9FC8D2Q33604003-D6ECF0ED-7D22-481B-95B4-54CBDDE4827BQ33805277-BEE785FA-2A06-4DF0-8FC2-82D259687C4FQ33824820-38E16717-8789-40CE-992E-DF5EC914FBB9Q33868782-A9166F47-61EA-4173-ACEA-1AB76D54D356Q33932598-82409713-BD25-483A-8905-DB1B8478AC30Q33997963-0147C87C-EC06-4A21-A4B8-5FC04F036B26Q34334697-FE6C97D2-440A-4208-BEE3-D1260E5F4940Q34382248-E264EB80-6D11-4219-B883-7058B504FD8CQ34560006-D64F4978-6E71-4C2A-A2E5-07E709E01B9DQ35747579-4F427B27-3E6C-4F52-809B-0DF62530591DQ35760064-CFFA1579-0BA5-4955-965E-667E81DD8249Q36193752-2271EA33-D285-46EE-B0F8-9B0DF596F02EQ36315574-F9DBE417-6163-46D4-A224-85FE68E25346Q36620946-85051E50-7258-403D-AB43-8D846CDD6571Q36681188-953BC6F2-D8CB-44B2-997C-D28ABC076631Q36989495-C4441C9B-604B-4CF6-8E94-B710A4E70EB9Q37037548-A30337B8-6866-42BF-A0E6-BA2736E4299DQ37290031-8D8C6D12-F4DF-455E-ACCB-102EA424AE3CQ37442901-A6472E8A-37F8-487D-935E-B4F4ED71471CQ37611333-A845DB2F-11E7-41A2-906B-0CA14B37CE90Q37957869-1577354A-2510-4A78-95F4-9BACED0A6B62Q38111810-47E0AF83-76EF-4C21-A37E-FFFED0D1F4D1Q38175374-9D27F99D-28FB-4DB6-A1FB-3966132B511CQ38896299-1AA0978B-BC62-4B46-8963-5F60C94BA7ECQ38963714-08D5239B-223B-4B11-B44C-0E42980446A2Q42879466-D9DBC14A-6A85-4E76-B88A-C808FCF4E8F0Q44246837-4CBB9D0E-3C79-4727-A1AC-25C91D5590C6Q47150117-19303EB3-A72D-4359-B4CF-333FDA253046Q47152874-885B1417-E275-4DAF-AE40-DC1441416FF1Q48271382-31D58765-9799-428E-B6DE-97F5D35CC341Q50894861-15764881-D193-4744-A5C1-704AF38B0383
P2860
Atheroprotective effects of HDL: beyond reverse cholesterol transport.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Atheroprotective effects of HDL: beyond reverse cholesterol transport.
@en
Atheroprotective effects of HDL: beyond reverse cholesterol transport.
@nl
type
label
Atheroprotective effects of HDL: beyond reverse cholesterol transport.
@en
Atheroprotective effects of HDL: beyond reverse cholesterol transport.
@nl
prefLabel
Atheroprotective effects of HDL: beyond reverse cholesterol transport.
@en
Atheroprotective effects of HDL: beyond reverse cholesterol transport.
@nl
P1433
P1476
Atheroprotective effects of HDL: beyond reverse cholesterol transport
@en
P2093
Jonathan E Feig
Raanan Shamir
P304
P356
10.2174/138945008783755557
P577
2008-03-01T00:00:00Z